Бассейн | Длительность: 3:32 | Просмотры: 4.1K
Купальщица в воде бассейна....
Автор: WeBoGir | Просмотров: 4.1K | Длительность: 3:32
Заверши строительство бассейнов в Абрау Дюрсо .Три бассейна размерами 17-8, 10-7 и кру...
1:23
744
Бассейнщик Юга | строительство бассейнов
Recent in vitro cardiac safety studies demonstrate the ability of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to detect electrophysiologic effects of drugs. However, … 2 дек. 2024 г. · This standard focuses on the hiPSC-cardiomyocyte spontaneous beat rate, features of the cardiac waveform (depolarization spike amplitude and field potential duration), and the … The Axion Biosystems software (AXiS) was used to quantify field potential duration (FPD), Na+ spike amplitude, and beating rate. In house algorithms were used to detect proarrhythmic events including … 1 сент. 2025 г. · Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM) have been proven to be useful in various in vitro cardiotoxicity applications. T… 25 сент. 2018 г. · Blinova et al. tested human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) for improving torsades de pointes arrhythmia risk prediction of drugs in the … • Baseline histograms were compiled across 14 separate 48-well plates for BP, AMP, FPDc (Fridericia), and BP Coefficient of Variability. • BP CoV and AMP passed the CiPA Phase 2 Protocol inclusion … The goal of this project is to set the minimum acceptance criteria for a spontaneous beating wild type hiPSC-ventricular cardiomyocyte field potential assay for compound testing and/or disease modeling. 19 мар. 2026 г. · In this study, we benchmarked the Paci2020 human induced pluripotent stem cell–derived cardiomyocyte (hiPSC-CM) in silico model for CiPA-aligned TdP risk prediction using an … 27 апр. 2018 г. · Utilization of a paced cardiomyocyte assay, whereby the beat rate is controlled through electrical or optogenetic stimulation, would eliminate variability due to changes in spontaneous … 1 окт. 2025 г. · Drug-induced arrhythmias remain a significant challenge in drug development, often leading to serious cardiovascular complications and the withdrawal …
